While serving at the Department of Health and Human Services, Calley Means attacked leading physician groups, federal agencies, and government scientists, claiming they protect their own interests

Evolving US policy battles over drug pricing and healthcare affordability, tracking legislation, court rulings, regulatory actions, and industry responses shaping costs, access, and market dynamics.